Quigley's bankruptcy case remains alive; next status conference set

By Lisa Kerner

Charlotte, N.C., Oct. 26 - A hearing on a motion to dismiss Quigley Co. Inc.'s bankruptcy case was adjourned with the parties' consent on Tuesday, according to an attorney familiar with the case.

A status conference will be held on Dec. 2.

As previously reported the company's informal committee of tort victims asked the U.S. Bankruptcy Court for the Southern District of New York earlier in the month to dismiss Quigley's bankruptcy case.

The court, at a Sept. 27 status conference, gave Quigley parent Pfizer Inc. an additional 30 days to come up with a plan to cure bad faith and other deficiencies. However, the tort victims group said no further extension is warranted.

On Sept. 8 the court denied confirmation of Quigley's latest plan. According to the court, the plan was not feasible, failed the best interest of creditors test, resulted in unequal treatment and was proposed in bad faith.

In a separate court filing, Pfizer appealed the order denying confirmation of the plan.

Quigley, a unit of Pfizer Inc., filed for bankruptcy on Sept. 3, 2004. Its Chapter 11 case number is 04-15739.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.